23-24 AUGUST 2023
Kuala Lumpur, MALAYSIA
Website best viewed on Desktop
SPEAKERS
PETER HOFFMAN (PLENARY)
Professor
Lloyd Sansom Chair, Director Tissue Mass Spectrometry Imaging Node
Clinical Health Sciences
University of South Australia
Prof Hoffmann is President of the Australasian Proteomics Society and Treasurer of the Asia-Oceania Human Proteome Organisation (AOHUPO). His research has delved into the identification of low abundant proteins and the mapping of their posttranslational modifications and their use as biomarkers for early detection of cancer. He is a leader in Mass Spectrometry Imaging and his research group was the first to use this technology in Australia. He is Director of the NCRIS Bioplatforms Australia Node for Tissue Mass Spectrometry Imaging. He has experience translation forming OncoDX to commercialise patented biomarkers for the early detection of ovarian and gastric cancer.
PAUL GLEESON (PLENARY)
Professor
Biochemistry and Pharmacology
Bio21 Institute, University of Melbourne (Australia)
​
Paul Gleeson is a molecular cell biologist who has contributed to the field of protein sorting and membrane trafficking in both the secretory and endocytic pathways for >30 years in a range of different systems, including primary cells and whole organisms. His current research is focused on neuronal cell biology and membrane trafficking defects associated Alzheimer’s disease. Paul established an independent laboratory at Monash University in 1986 and in 2001 moved to the University of Melbourne where he was Head of the Biochemistry and Molecular Biology Department from 2006-2016. He has been a visiting scientist at the EMBL, Heidelberg and Institut Curie, Paris and has published >185 articles/reviews.
​CARMAY LIM
Distinguished Research Fellow
Institute of Biomedical Sciences
Academia Sinica (Taiwan)
​
Prof. Lim obtained her Ph.D. degree in Chemical Physics from the University of Minnesota, Minneapolis and carried out postdoctoral research at AT&T Bell Laboratories, Murray Hill and at Harvard University. She joined the faculties of the Departments of Medical Genetics, Biochemistry, and Chemistry at the University of Toronto and moved to the Institute of Biomedical Sciences at Academia Sinica, Taiwan in 1995. Her research focuses on unraveling the principles governing biological processes and applying them to guide drug design, identify new drug targets, elucidate drug action mechanism.
AKIRA KIKUCHI
Specially Appointed Professor / Director
Planning & Management Office
Center for Infectious Disease Education and Research, Osaka University (Japan)
Akira Kikuchi graduated from Kobe University, School of Medicine (Kobe, Japan) (M.D.) in 1982, and started the initial clinical training as a physician. During the clinical training, he also studied biochemistry as a post-graduate student. There he clarified the physiological significance of multiplicity of small GTP-binding proteins (G proteins) and their regulatory proteins. In 1989 he received Ph.D. in Biochemistry, and was appointed to an Assistant Professor at Department of Biochemistry, Graduate School of Medicine, Kobe University. He is currently studying the underlying mechanism by which Wnt and other growth factor signaling co-operatively regulate epithelial morphogenesis and also developing new anti-cancer drugs based on his own discovered-molecules which are involved in epithelial morphogenesis. In 2022 he is serving as a Specially Appointed Professor and Director of Planning and Manager Office, CiDER.
​THAMIL SELVEE RAMASAMY
Senior Lecturer
Department of Molecular Medicine
Faculty of Medicine, Universiti Malaya (Malaysia)
Dr. Ramasamy earned her PhD in Clinical Medicine Research Programme (specialisation: human embryonic stem cell research) from Imperial College London, UK. She is heading the Stem Cell Biology Laboratory at University of Malaya. Unravelling the role of stem cell in development of therapy for ageing-associated degenerative diseases and targeting cancer resistance is the primary focus of her research team. Her passion in bringing the impact of research in Malaysia to a great height is very much evident through many leadership roles that she held; including as the advisor to Minister of Science, Technology and Innovation (MOSTI), Special Officer to Health Minister (MOH), President of Tissue Engineering and Regenerative Medicine Society of Malaysia (TESMA) at national level and many administrative roles at institutional level.
TAN SIANG HEE
Executive Director
CropLife Asia (Malaysia)
Dr. Siang Hee Tan is the Executive Director of CropLife Asia, responsible for overseeing the Crop Protection Regulatory Affairs, Intellectual Property Rights, Seeds and Biotechnology, and Advocacy & Outreach programs in 15 Asian countries. He is actively involved in UN initiatives, including "The 2030 Agenda for Sustainable Development." With extensive professional experience in establishing research centers and managing start-up ventures, Dr. Tan holds a BSc in Plant Pathology, an MSc in Genetic Engineering, and a PhD in Molecular Biology (Plant Virus). He has received numerous professional recognitions, including a Silver Award at the 2005 Geneva International Exhibitions & Inventions of New Techniques and Products, a US Government Cochran Fellowship, and UPM awards for Research and Development. Dr. Tan also serves on the Advisory Council for GRAFT Challenge Vietnam, and as a member of Monash, Malaysia Industry Advisory Board and Chung Ling High School center region scholarship committee.
TAN JUN JIE
Associate Professor
Department of Biomedical Sciences
Universiti Sains Malaysia (Malaysia)
With over 15 years of experience in stem cell research, Jun Jie is convinced that it is the key to achieving heart regeneration. In 2016, he commenced his research on human induced pluripotent stem cells, and he has successfully developed cardiomyocytes from cord blood donated by Malaysians. He has been the recipient of Young Investigator Awards at both regional and local conferences, and he has been honored with the Excellence Service Award twice during his tenure at USM. Jun Jie is now an Associate Professor and the Head of the heart failure research initiative at the Advanced Medical and Dental Institute at USM. Additionally, he is a research partner with Cryocord Malaysia Sdn Bhd and ALPS Global Holding, and maintains strong partnerships with esteemed research institutions both locally and internationally.
​NAZLINA HAIZA MOHD YASIN
Senior Lecturer
Department of Biological Sciences and Biotechnology
Faculty of Science and Technology, Universiti Kebangsaan Malayia (Malaysia)
Dr. Nazlina Haiza Mohd Yasin is a senior lecturer at the Faculty of Science and Technology, UKM. She graduated from the Kyushu Institute of Technology, Japan before joining the Algae Research Group at UKM that is headed by Prof. Ir. Dr. Mohd Sobri Takriff in 2016 as a post-doc research fellow. Her expertise is in the area of Environmental Microbiology and Bioprocess Technology. Professionally she is a member of Malaysian Academic Research on Palm Oil Sustainability (ARPOS) Network. With her passion for research , Dr Nazlina Haiza has successfully develop the “Fun with Microbes@UKM” teaching module to enhance students interest and understanding of Microbiology. She is very active in research work on topics related to microalgae and has successfully established collaboration with the industries and communities.
​ANNIE CHAI WAI YEENG
Deputy Head
Translational Cancer Biology Research Unit
Cancer Research Malaysia (Malaysia)
Dr. Annie Chai is the Deputy Head of the Translational Cancer Biology Research Unit at Cancer Research Malaysia. After completing a PhD at The University of Hong Kong (with Prof Maria Lung), she joined Cancer Research Malaysia and led one of the first oral cancer genome-wide CRISPR/Cas9 essential screens. She is now working on promising therapeutic targets from the screen to identify effective treatments for Asian cancers, such as oral and nasopharyngeal cancers. Dr Chai has won several awards including the Ranjeet Bhagwan Singh Research Grant, the AACR GISTA and the ASEAN-ROK Next ASEAN Innovator Award 2022.